Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials

Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials

Introduction section, para 3, lines 2–4 which previously read.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical pharmacokinetics 2019-05, Vol.58 (5), p.685-685
Hauptverfasser: Qi, Yulan, McKeever, Kathleen, Taylor, Julie, Haller, Christine, Song, Wenjie, Jones, Simon A., Shi, Jack
Format: Artikel
Sprache:eng
Schlagworte:
Correction
Internal Medicine
Medicine
Medicine & Public Health
Pharmacology/Toxicology
Pharmacotherapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 685
container_issue 5
container_start_page 685
container_title Clinical pharmacokinetics
container_volume 58
creator Qi, Yulan
McKeever, Kathleen
Taylor, Julie
Haller, Christine
Song, Wenjie
Jones, Simon A.
Shi, Jack
description Introduction section, para 3, lines 2–4 which previously read.
doi_str_mv 10.1007/s40262-018-0726-6
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6828067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2150527235</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2396-8e71ef88a74f0ac2334313d96d1885081ed6ea45f447a1b14d70353ebee0c0083</originalsourceid><addsrcrecordid>eNp9ksFu1DAQhi0EotuFB-CCfORAwHYSx9sDUrW0sFKrVmjp1fI6k12XxE7tBJS-K-_ClC0ruHAa-5-Zb0ajn5BXnL3jjFXvU8GEFBnjKmOVkJl8QmacV4uML4R8SmYs5yIrFzI_Iscp3TLGlGDsOTnKWcnLiqsZ-bkMMYIdXPB0CCf0emdiZ2z45jwMzlLj64NWT950qF2GGlrnt9hAr_rBde4e6LAD-jEkoKGhN5CGGLyrDf5P28a8RQ498_dTB_QL9K2x0IEf6HoH0fQTbUKk6whm-K0i4doMDp-J_nDDjl6ONvShnZKxFndxdUgu0fXUA71ZrU4QmcYWi5sYOmRGAKQ506YX5FmDAV4-xjn5en62Xn7OLq4-rZanF5kV-UJmCioOjVKmKhpmUMuLnOf1QtZcqZIpDrUEU5RNUVSGb3hRVywvc9gAMItHzefkw57bj5sOaourR9PqPrrOxEkH4_S_Ge92ehu-a6mEYrJCwJtHQAx3I55Pdy5ZaFvjIYxJC16yUlQCp84J35faGFKK0BzGcKYfbKH3ttBoC_1gCy2x5_Xf-x06_vgAC8S-IGHKbyHq2zBGjzf7D_UXla_IpA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2150527235</pqid></control><display><type>article</type><title>Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials</title><source>SpringerLink Journals - AutoHoldings</source><creator>Qi, Yulan ; McKeever, Kathleen ; Taylor, Julie ; Haller, Christine ; Song, Wenjie ; Jones, Simon A. ; Shi, Jack</creator><creatorcontrib>Qi, Yulan ; McKeever, Kathleen ; Taylor, Julie ; Haller, Christine ; Song, Wenjie ; Jones, Simon A. ; Shi, Jack</creatorcontrib><description>Introduction section, para 3, lines 2–4 which previously read.</description><identifier>ISSN: 0312-5963</identifier><identifier>EISSN: 1179-1926</identifier><identifier>DOI: 10.1007/s40262-018-0726-6</identifier><identifier>PMID: 30515718</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Correction ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; Pharmacology/Toxicology ; Pharmacotherapy</subject><ispartof>Clinical pharmacokinetics, 2019-05, Vol.58 (5), p.685-685</ispartof><rights>The Author(s) 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40262-018-0726-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40262-018-0726-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30515718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Qi, Yulan</creatorcontrib><creatorcontrib>McKeever, Kathleen</creatorcontrib><creatorcontrib>Taylor, Julie</creatorcontrib><creatorcontrib>Haller, Christine</creatorcontrib><creatorcontrib>Song, Wenjie</creatorcontrib><creatorcontrib>Jones, Simon A.</creatorcontrib><creatorcontrib>Shi, Jack</creatorcontrib><title>Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials</title><title>Clinical pharmacokinetics</title><addtitle>Clin Pharmacokinet</addtitle><addtitle>Clin Pharmacokinet</addtitle><description>Introduction section, para 3, lines 2–4 which previously read.</description><subject>Correction</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacotherapy</subject><issn>0312-5963</issn><issn>1179-1926</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9ksFu1DAQhi0EotuFB-CCfORAwHYSx9sDUrW0sFKrVmjp1fI6k12XxE7tBJS-K-_ClC0ruHAa-5-Zb0ajn5BXnL3jjFXvU8GEFBnjKmOVkJl8QmacV4uML4R8SmYs5yIrFzI_Iscp3TLGlGDsOTnKWcnLiqsZ-bkMMYIdXPB0CCf0emdiZ2z45jwMzlLj64NWT950qF2GGlrnt9hAr_rBde4e6LAD-jEkoKGhN5CGGLyrDf5P28a8RQ498_dTB_QL9K2x0IEf6HoH0fQTbUKk6whm-K0i4doMDp-J_nDDjl6ONvShnZKxFndxdUgu0fXUA71ZrU4QmcYWi5sYOmRGAKQ506YX5FmDAV4-xjn5en62Xn7OLq4-rZanF5kV-UJmCioOjVKmKhpmUMuLnOf1QtZcqZIpDrUEU5RNUVSGb3hRVywvc9gAMItHzefkw57bj5sOaourR9PqPrrOxEkH4_S_Ge92ehu-a6mEYrJCwJtHQAx3I55Pdy5ZaFvjIYxJC16yUlQCp84J35faGFKK0BzGcKYfbKH3ttBoC_1gCy2x5_Xf-x06_vgAC8S-IGHKbyHq2zBGjzf7D_UXla_IpA</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Qi, Yulan</creator><creator>McKeever, Kathleen</creator><creator>Taylor, Julie</creator><creator>Haller, Christine</creator><creator>Song, Wenjie</creator><creator>Jones, Simon A.</creator><creator>Shi, Jack</creator><general>Springer International Publishing</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190501</creationdate><title>Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials</title><author>Qi, Yulan ; McKeever, Kathleen ; Taylor, Julie ; Haller, Christine ; Song, Wenjie ; Jones, Simon A. ; Shi, Jack</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2396-8e71ef88a74f0ac2334313d96d1885081ed6ea45f447a1b14d70353ebee0c0083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Correction</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qi, Yulan</creatorcontrib><creatorcontrib>McKeever, Kathleen</creatorcontrib><creatorcontrib>Taylor, Julie</creatorcontrib><creatorcontrib>Haller, Christine</creatorcontrib><creatorcontrib>Song, Wenjie</creatorcontrib><creatorcontrib>Jones, Simon A.</creatorcontrib><creatorcontrib>Shi, Jack</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical pharmacokinetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qi, Yulan</au><au>McKeever, Kathleen</au><au>Taylor, Julie</au><au>Haller, Christine</au><au>Song, Wenjie</au><au>Jones, Simon A.</au><au>Shi, Jack</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials</atitle><jtitle>Clinical pharmacokinetics</jtitle><stitle>Clin Pharmacokinet</stitle><addtitle>Clin Pharmacokinet</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>58</volume><issue>5</issue><spage>685</spage><epage>685</epage><pages>685-685</pages><issn>0312-5963</issn><eissn>1179-1926</eissn><abstract>Introduction section, para 3, lines 2–4 which previously read.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>30515718</pmid><doi>10.1007/s40262-018-0726-6</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0312-5963
ispartof Clinical pharmacokinetics, 2019-05, Vol.58 (5), p.685-685
issn 0312-5963
1179-1926
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6828067
source SpringerLink Journals - AutoHoldings
subjects Correction
Internal Medicine
Medicine
Medicine & Public Health
Pharmacology/Toxicology
Pharmacotherapy
title Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T10%3A08%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction%20to:%20Pharmacokinetic%20and%20Pharmacodynamic%20Modeling%20to%20Optimize%20the%20Dose%20of%20Vestronidase%20Alfa,%20an%20Enzyme%20Replacement%20Therapy%20for%20Treatment%20of%20Patients%20with%20Mucopolysaccharidosis%20Type%20VII:%20Results%20from%20Three%20Trials&rft.jtitle=Clinical%20pharmacokinetics&rft.au=Qi,%20Yulan&rft.date=2019-05-01&rft.volume=58&rft.issue=5&rft.spage=685&rft.epage=685&rft.pages=685-685&rft.issn=0312-5963&rft.eissn=1179-1926&rft_id=info:doi/10.1007/s40262-018-0726-6&rft_dat=%3Cproquest_pubme%3E2150527235%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2150527235&rft_id=info:pmid/30515718&rfr_iscdi=true